Drugs Approved for Leukemia
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for leukemia. The list includes generic and brand names. This page also lists common drug combinations used in leukemia. The individual drugs in the combinations are FDA-approved. However, drug combinations themselves usually are not approved, but are widely used.
The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in leukemia that are not listed here.
Drugs Approved for Acute Lymphoblastic Leukemia (ALL)
- Arranon (Nelarabine)
- Asparaginase Erwinia Chrysanthemi
- Asparaginase Erwinia Chrysanthemi (Recombinant)-rywn
- Asparlas (Calaspargase Pegol-mknl)
- Aucatzyl (Obecabtagene Autoleucel)
- Besponsa (Inotuzumab Ozogamicin)
- Blinatumomab
- Blincyto (Blinatumomab)
- Calaspargase Pegol-mknl
- Clofarabine
- Clolar (Clofarabine)
- Cyclophosphamide
- Cytarabine
- Dasatinib
- Daunorubicin Hydrochloride
- Dexamethasone
- Doxorubicin Hydrochloride
- Erwinaze (Asparaginase Erwinia Chrysanthemi)
- Gleevec (Imatinib Mesylate)
- Iclusig (Ponatinib Hydrochloride)
- Inotuzumab Ozogamicin
- Imatinib Mesylate
- Imkeldi (Imatinib Mesylate)
- Kymriah (Tisagenlecleucel)
- Mercaptopurine
- Methotrexate Sodium
- Nelarabine
- Obecabtagene Autoleucel
- Oncaspar (Pegaspargase)
- Pemazyre (Pemigatinib)
- Pemigatinib
- Pegaspargase
- Ponatinib Hydrochloride
- Prednisone
- Purinethol (Mercaptopurine)
- Purixan (Mercaptopurine)
- Revuforj (Revumenib Citrate)
- Revumenib Citrate
- Rituxan (Rituximab)
- Rituximab
- Rylaze (Asparaginase Erwinia Chrysanthemi [Recombinant]-rywn)
- Sprycel (Dasatinib)
- Tisagenlecleucel
- Trexall (Methotrexate Sodium)
- Vincristine Sulfate
Drug Combinations Used in Acute Lymphoblastic Leukemia (ALL)
Drugs Approved for Acute Myeloid Leukemia (AML)
- Arsenic Trioxide
- Azacitidine
- Cyclophosphamide
- Cytarabine
- Daunorubicin Hydrochloride
- Daunorubicin Hydrochloride and Cytarabine Liposome
- Daurismo (Glasdegib Maleate)
- Dexamethasone
- Doxorubicin Hydrochloride
- Enasidenib Mesylate
- Gemtuzumab Ozogamicin
- Gilteritinib Fumarate
- Glasdegib Maleate
- Grafapex (Treosulfan)
- Idamycin PFS (Idarubicin Hydrochloride)
- Idarubicin Hydrochloride
- Idhifa (Enasidenib Mesylate)
- Ivosidenib
- Midostaurin
- Mitoxantrone Hydrochloride
- Mylotarg (Gemtuzumab Ozogamicin)
- Olutasidenib
- Onureg (Azacitidine)
- Pemazyre (Pemigatinib)
- Pemigatinib
- Prednisone
- Quizartinib Dihydrochloride
- Revuforj (Revumenib Citrate)
- Revumenib Citrate
- Rezlidhia (Olutasidenib)
- Rydapt (Midostaurin)
- Tabloid (Thioguanine)
- Thioguanine
- Tibsovo (Ivosidenib)
- Tisagenlecleucel (Kymriah)
- Treosulfan
- Trisenox (Arsenic Trioxide)
- Vanflyta (Quizartinib Dihydrochloride)
- Venclexta (Venetoclax)
- Venetoclax
- Vincristine Sulfate
- Vyxeos (Daunorubicin Hydrochloride and Cytarabine Liposome)
- Xospata (Gilteritinib Fumarate)
Drug Combinations Used in Acute Myeloid Leukemia (AML)
Drugs Approved for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Drugs Approved for Chronic Lymphocytic Leukemia (CLL)
- Acalabrutinib Maleate Monohydrate
- Alemtuzumab
- Arzerra (Ofatumumab)
- Bendamustine Hydrochloride
- Bendeka (Bendamustine Hydrochloride)
- Breyanzi (Lisocabtagene Maraleucel)
- Brukinsa (Zanubrutinib)
- Calquence (Acalabrutinib Maleate Monohydrate)
- Campath (Alemtuzumab)
- Chlorambucil
- Copiktra (Duvelisib)
- Cyclophosphamide
- Dexamethasone
- Duvelisib
- Fludarabine Phosphate
- Gazyva (Obinutuzumab)
- Ibrutinib
- Idelalisib
- Imbruvica (Ibrutinib)
- Jaypirca (Pirtobrutinib)
- Leukeran (Chlorambucil)
- Lisocabtagene Maraleucel
- Obinutuzumab
- Ofatumumab
- Pirtobrutinib
- Prednisone
- Riabni (Rituximab)
- Rituxan (Rituximab)
- Rituxan Hycela (Rituximab and Hyaluronidase Human)
- Rituximab
- Rituximab and Hyaluronidase Human
- Ruxience (Rituximab)
- Treanda (Bendamustine Hydrochloride)
- Truxima (Rituximab)
- Venclexta (Venetoclax)
- Venetoclax
- Zanubrutinib
- Zydelig (Idelalisib)
Drug Combinations Used in Chronic Lymphocytic Leukemia (CLL)
Drugs Approved for Chronic Myelogenous Leukemia (CML)
- Asciminib Hydrochloride
- Bosulif (Bosutinib)
- Bosutinib
- Busulfan
- Busulfex (Busulfan)
- Cyclophosphamide
- Cytarabine
- Dasatinib
- Dexamethasone
- Gleevec (Imatinib Mesylate)
- Hydrea (Hydroxyurea)
- Hydroxyurea
- Iclusig (Ponatinib Hydrochloride)
- Imatinib Mesylate
- Imkeldi (Imatinib Mesylate)
- Myleran (Busulfan)
- Nilotinib
- Omacetaxine Mepesuccinate
- Ponatinib Hydrochloride
- Scemblix (Asciminib Hydrochloride)
- Sprycel (Dasatinib)
- Synribo (Omacetaxine Mepesuccinate)
- Tasigna (Nilotinib)
Drugs Approved for Hairy Cell Leukemia
Drugs Approved for Mast Cell Leukemia
Drugs Approved for Meningeal Leukemia